Cargando…
Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release
Drug targeting to the colon via the oral administration route for local treatment of e.g. inflammatory bowel disease and colonic cancer has several advantages such as needle-free administration and low infection risk. A new source for delivery is plant-polysaccharide based delivery platforms such as...
Autores principales: | Svagan, Anna J., Kusic, Anja, De Gobba, Cristian, Larsen, Flemming H., Sassene, Philip, Zhou, Qi, van de Weert, Marco, Mullertz, Anette, Jørgensen, Bodil, Ulvskov, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167381/ https://www.ncbi.nlm.nih.gov/pubmed/27992455 http://dx.doi.org/10.1371/journal.pone.0168050 |
Ejemplares similares
-
Diversity of Pectin Rhamnogalacturonan I Rhamnosyltransferases in Glycosyltransferase Family 106
por: Wachananawat, Bussarin, et al.
Publicado: (2020) -
Conformational Properties of Flaxseed Rhamnogalacturonan-I and Correlation between Primary Structure and Conformation
por: Guo, Qingbin, et al.
Publicado: (2022) -
Rhamnogalacturonan‐I is a determinant of cell–cell adhesion in poplar wood
por: Yang, Haibing, et al.
Publicado: (2019) -
Synthesis of Two Tetrasaccharide Pentenyl Glycosides Related to the Pectic Rhamnogalacturonan I Polysaccharide
por: Zakharova, Alexandra N., et al.
Publicado: (2018) -
Fibrin-Rhamnogalacturonan I Composite Gel for Therapeutic Enzyme Delivery to Intestinal Tumors
por: Faizullin, Dzhigangir, et al.
Publicado: (2023)